Compare · AMIX vs MDLN
AMIX vs MDLN
Side-by-side comparison of Autonomix Medical Inc. (AMIX) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMIX and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 8372.3x AMIX ($5.7M).
- MDLN has been more active in the news (7 items in the past 4 weeks vs 3 for AMIX).
- MDLN has more recent analyst coverage (25 ratings vs 0 for AMIX).
- Company
- Autonomix Medical Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- $5.7M
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- 2025
- News (4w)
- 3
- 7
- Recent ratings
- 0
- 25
Latest AMIX
- SEC Form 3 filed by Autonomix Medical Inc.
- Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
- Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
- Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
- CFO Smith Trent N. was granted 15,000 shares, increasing direct ownership by 12,605% to 15,119 units (SEC Form 4)
- SEC Form 424B3 filed by Autonomix Medical Inc.
- Autonomix Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
- SEC Form EFFECT filed by Autonomix Medical Inc.
- SEC Form DEFA14A filed by Autonomix Medical Inc.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M